The Claim
In human lung adenocarcinoma tissues, PCK2 and SLC38A2 protein and mRNA expression levels are significantly higher in tumor tissue than in adjacent non-tumor tissue, and the expression levels of PCK2 and SLC38A2 are positively correlated.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In human lung cancer tissues, the levels of PCK2 and SLC38A2 proteins and messenger RNA are higher than in nearby non-cancerous lung tissue, and the levels of these two molecules increase together.
See the scientific wording
In human lung adenocarcinoma tissues, PCK2 and SLC38A2 protein and mRNA expression levels are significantly higher in tumor tissue compared to adjacent non-tumor tissue, and their expression levels are positively correlated, suggesting a potential clinical association between this metabolic pathway and tumor development.
When glucose is low, cancer cells in the lung make more PCK2, which turns on AMPK, which then activates CEBPB. CEBPB tells the cell to make more SLC38A2, a protein that pulls glutamine inside. The glutamine feeds into energy production and building blocks needed for the cancer to grow and spread, even without glucose.
What the research says
1 studyThe study found that two proteins, PCK2 and SLC38A2, are more common in lung cancer tumors than in healthy lung tissue, and they work together to help cancer cells grow — exactly what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.